[Central serous chorioretinopathy: A review].
Choriorétinopathie séreuse centrale : une revue.
Central serous chorioretinopathy
Choriorétinopathie séreuse centrale
Choroidopathy
Choroïdopathie
Décollement de l’épithélium pigmentaire
Décollement séreux rétinien
Laser
Photodynamic therapy
Photothérapie dynamique
Pigment epithelium detachment
Serous retinal detachment
Journal
Journal francais d'ophtalmologie
ISSN: 1773-0597
Titre abrégé: J Fr Ophtalmol
Pays: France
ID NLM: 7804128
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
03
02
2023
accepted:
12
02
2023
medline:
29
8
2023
pubmed:
6
6
2023
entrez:
5
6
2023
Statut:
ppublish
Résumé
The central serous chorioretinopathy (CSCR) is characterized by serous retinal detachments SRD associated with one or several retinal pigment epithelium detachments/irregularities (PEDs). The choroid is thickened with dilated choroidal veins and choroidal hyperpermeability suggesting an underlying choroidopathy. CSCR belongs to the pachychoroid spectrum. CSCR affects mostly middle-aged men and the main risk factor is the corticosteroid intake. In most cases, the subretinal detachment resolves spontaneously with a good visual prognosis. However, recurrent or chronic form of the disease can lead to irreversible retinal damage and decreased visual acuity. Laser on an extra foveal leak point or half dose/half fluence photodynamic therapy are the first-line treatment options.
Identifiants
pubmed: 37277234
pii: S0181-5512(23)00123-7
doi: 10.1016/j.jfo.2023.02.003
pii:
doi:
Types de publication
English Abstract
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
791-802Informations de copyright
Copyright © 2023. Published by Elsevier Masson SAS.